Overview

Special Drug Use Investigation for ALLERMIST (Long Term)

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This post-marketing surveillance study is to investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray for long-term use in Japanese subjects with allergic rhinitis under the conditions of actual practical use.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone